文献速递血栓与止血

孕妇对产后血栓预防的偏好:双中心PREFER-PostPartum研究

Preferences of pregnant women for postpartum thromboprophylaxis: the bicentric PREFER-PostPartum study.
PubMed 文献 · J Thromb Haemost · 2024-07-05

在瑞士和法国两家妇产医院对122名孕妇或产后女性进行结构化访谈,采用标准博弈或时间权衡法评估健康状态效用,并通过直接选择法评估不同产后静脉血栓栓塞症(VTE)和出血风险下使用低分子肝素(LMWH)短期预防的偏好。孕妇对产后10天血栓预防的意愿较高,即使VTE风险很低也倾向于预防而非不治疗。

要点

  • 肺栓塞效用中位数0.725,产后出血0.75,深静脉血栓0.85,LMWH注射0.96。
  • 无LMWH相关出血风险时,偏好预防而非不治疗的产后VTE风险中位数为0.1%。
  • 有1%出血风险时,偏好预防的产后VTE风险中位数为0.2%。

核心结论

  • 欧洲孕妇对产后10天血栓预防的意愿较高,即使产后VTE风险很低也倾向于预防而非不治疗。
  • 作者认为这一患者视角支持迫切需要开展随机试验评估产后血栓预防的疗效和安全性。

研究设计与样本

  • 在2家瑞士和法国妇产医院对孕妇或产后女性进行结构化访谈。
  • 共纳入122名参与者。
  • 首先将女性随机分配至标准博弈或时间权衡法以评估健康状态效用(生活质量,0至1)。
  • 其次通过直接选择练习评估在不同产后VTE和出血风险下使用短期产后LMWH血栓预防 vs 不预防的偏好。

主要发现

  • 肺栓塞效用中位数(IQR)为0.725(0.30-0.925)。
  • 产后出血效用中位数(IQR)为0.75(0.40-0.97)。
  • 深静脉血栓效用中位数(IQR)为0.85(0.60-0.97)。
  • LMWH注射效用中位数(IQR)为0.96(0.96-0.999)。
  • 无LMWH相关出血风险时,偏好产后血栓预防而非不治疗的产后VTE风险中位数为0.1%(IQR,0.01%-0.50%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Clinical guidelines for postpartum thromboprophylaxis differ due to its uncertain effect and varying preferences of experts. Women's preferences for postpartum thromboprophylaxis are unknown, although they may inform practices and future research. OBJECTIVES: Our aim was to elicit the pregnant women's preferences for postpartum thromboprophylaxis according to different risks of venous thromboembolism (VTE) and bleeding. METHODS: In 2 Swiss and French maternity hospitals, we conducted structured interviews of pregnant or postpartum women. Participants were instructed on pulmonary embolism, deep vein thrombosis, postpartum hemorrhage, and subcutaneous injections of low-molecular-weight heparin (LMWH). First, we randomized women to either standard gamble or time trade-off (2 different validated methods) to estimate the utilities (quality of life, from 0 to 1) of these health states. Second, we elicited the preference for the use of short-term postpartum thromboprophylaxis with LMWH vs none across different risks of postpartum VTE and bleeding through direct-choice exercises. RESULTS: Among 122 participants, median (IQR) health state utilities were 0.725 (0.30-0.925) for pulmonary embolism, 0.75 (0.40-0.97) for postpartum hemorrhage, 0.85 (0.60-0.97) for deep vein thrombosis, and 0.96 (0.96-0.999) for LMWH injections. The median risk of postpartum VTE for preference of the use of postpartum thromboprophylaxis over no treatment was 0.1% (IQR, 0.01%-0.50%) without LMWH-associated bleeding risk and 0.2% (IQR, 0.1%-5%) with a 1% bleeding risk. CONCLUSION: European pregnant women appear to have a high willingness for 10-day postpartum thromboprophylaxis, preferred over no treatment even for low risks of postpartum VTE. This perspective from patients supports the urgent need for a randomized trial evaluating the efficacy and safety of postpartum thromboprophylaxis.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Blondon M, Lansiaux M, Bryan S, et al. Preferences of pregnant women for postpartum thromboprophylaxis: the bicentric PREFER-PostPartum study. J Thromb Haemost. 2024. PMID: 38972385. doi:10.1016/j.jtha.2024.06.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。